Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George F Tidmarsh

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Critical Care (London, England)|February 8, 2020
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shockRinaldo Bellomo, Richard G Wunderink, Harold Szerlip, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
The New England Journal of Medicine|May 23, 2017
Angiotensin II for the Treatment of Vasodilatory ShockAshish Khanna, Shane W English, Xueyuan S Wang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Critical Care (London, England)|February 8, 2020
Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shockRinaldo Bellomo, Richard G Wunderink, Harold Szerlip, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
The New England Journal of Medicine|May 23, 2017
Angiotensin II for the Treatment of Vasodilatory ShockAshish Khanna, Shane W English, Xueyuan S Wang, et al.
Pageof 2